REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM NEW
Total 13F shares
30,169,407
Share change
+2,129,075
Total reported value
$9,535,000
Put/Call ratio
0%
Price per share
$0.32
Number of holders
36
Value change
-$1,032,200
Number of buys
13
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q4 2021

As of 31 Dec 2021, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,169,407 shares. The largest 10 holders included NEA Management Company, LLC, DAFNA Capital Management LLC, Empery Asset Management, LP, VANGUARD GROUP INC, Asymmetry Capital Management, L.P., VICTORY CAPITAL MANAGEMENT INC, Sarissa Capital Management LP, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.